Polar Capital Holdings PLC Infinity Pharmaceuticals, Inc. Transaction History

Polar Capital Holdings PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.46 - $1.21 $1.35 Million - $3.54 Million	-2,928,758 Reduced 58.58%	2,071,242 $1.16 Million
Q4 2021 Feb 14, 2022	BUY	$1.86 - $3.36 $4.65 Million - $8.4 Million	2,500,000 Added 100.0%	5,000,000 $11.3 Million
Q3 2021 Nov 15, 2021	BUY	$1.52 - $3.82 $3.8 Million - $9.55 Million	2,500,000 New	2,500,000 $8.55 Million

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.